What ILife Consulting does

ILife Consulting S.A.S. is a Paris-based, full-service Contract Research Organisation founded in 2013 by Marina Iché, providing clinical development services to small and mid-sized European and North American biotech companies. Its core offerings are organized into four pillars: Clinical Development Strategy, Clinical Study Conduct (CRO activity), Clinical Oversight, and Clinical Operations Externalization, supported by service modules in scientific/medical writing, clinical monitoring and site management, project management (including CTIS submissions), clinical gap analysis, and recruitment/training. The firm specializes in Phase I and Phase II trials, with particular depth in oncology (including basket studies), rare diseases, and innovative modalities such as cell therapy, gene therapy, monoclonal antibodies, and vaccines.

Underlying technology comprises a user-friendly Clinical Trial Management System (CTMS) and partnerships for electronic data capture (eCRF), eDiary/eCOA, IRT, and eTMF systems, with risk-based monitoring and risk-adapted quality management. The delivery model blends an office-based core team of Clinical Research Associates, Project Managers, and Therapeutic/Regulatory Directors with a network of long-term freelance CRA collaborators across Europe, augmented by North American CRO partnerships for US and Canada site monitoring.

Commercially, ILife operates on a professional-services, quote-based engagement model with no publicly disclosed pricing tiers. GTM is enterprise field sales driven by direct outreach, industry conferences, ecosystem memberships (notably the Paris Saclay Cancer Cluster), and a heavily referral-driven funnel — the firm reports that 90% of clients are repeats or referrals, with 20+ active clients, 1000+ patients treated, and 1500+ monitoring visits. Since June 3, 2025, ILife Consulting has operated as a subsidiary of Comac Medical Group within a pan-European full-service CRO platform.

Name

ILife Consulting

Legal name

ILife Consulting S.A.S.

Website

https://ilifeconsulting.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

ILife Consulting is a Paris-based full-service CRO providing Phase I/II clinical development, monitoring, oversight, and clinical operations externalization primarily to small and mid-sized European and North American biotechs, with deep specialization in oncology and rare diseases.

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Clinical research services
• Biotech CRO services
• Clinical trial management
• Clinical development consulting
• Contract research organization

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Operations Services: Full-service CRO providing clinical development strategy, clinical study conduct, clinical oversight, and clinical operations externalization. Services include project management, clinical monitoring, regulatory submissions, vendor management, and training/upskilling.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions for biotech companies. It delivers four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct, and Clinical Oversight, supported by modules including scientific and medical writing, clinical monitoring and site management, recruitment and training, clinical gap analysis, and project management. Services span feasibility through Clinical Study Report delivery for small and mid-sized life science companies developing innovative therapies, primarily in oncology and rare diseases.

Product overview

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions to biotech companies. The company offers a unified platform of clinical development services comprising four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct (CRO activity), and Clinical Oversight. These core offerings are supplemented by specialized service modules including Scientific and Medical Writing, Clinical Monitoring & Site Management, Recruitment and Training, Clinical Gap Analysis, and Project Management. The platform enables small and mid-sized life science companies to externalize or enhance their clinical operations through tailored, value-creating solutions spanning feasibility assessments through Clinical Study Report delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Operations Externalization Full externalization of clinical operations for small and mid-sized life science companies, including day-to-day clinical operations management, participation in executive committees, board meetings, and investigator meetings. Intended for biotech sponsors that lack or choose not to staff full internal clinical operations teams.
• Clinical Development Strategy Customized clinical development strategy services, including basket study design, expert and vendor identification, regulatory submission assistance, and risk analyses. Designed to create value and meet biotech client objectives across small molecules, mAbs, cell therapy, gene therapy, and vaccines.
• Clinical Study Conduct (CRO activity) Full CRO activity encompassing study startup, regulatory submissions, project management, risk management, vendor management, and clinical monitoring and site management across Europe. Delivered for sponsors needing end-to-end clinical trial execution.
• Clinical Oversight Clinical consulting services to de-risk clinical trials when conducted by another selected CRO, including CRO selection assistance, coordination, supervision, and strategic clinical input. Aimed at sponsors that retain ILife as an independent strategic advisor while another CRO executes the trial.
• Scientific and Medical Writing Development of clinical documentation including synopsis, protocol, monitoring plan, Informed Consent Form, Pharmacy Manual, SOPs, and Case Report Forms. Supports biotech clients and investigative teams preparing clinical trial materials.
• Clinical Monitoring and Site Management On-site and remote clinical monitoring in accordance with ICH-GCP standards, including risk-based monitoring, site training, and performance management throughout Europe. Delivered by office-based and freelance CRA collaborators.
• Recruitment and Training Training and upskilling of Clinical Operations collaborators to regulatory and GCP standards, delivered by seasoned Clinical Project Managers. Tailored for biotech sponsors building or reinforcing internal clinical operations capability.
• Clinical Gap Analysis Proactive review of clinical study processes and procedures to identify potential sources of dysfunction, evaluate performances, and ensure optimal conduct of clinical studies. Used to support trial rescue engagements and quality improvement initiatives.
• Project Management Centralized project management from study initiation to close out, including CTMS administration, vendor management, CTA submissions via CTIS, and regulatory authority support, serving biotech sponsors needing a single accountable project owner.

Quantifiable outcome

• 90% of clients are repeats or referrals
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and supporting.

• Comac Medical GroupcoreOthers · 3 June 2025ILife Consulting was acquired by Comac Medical Group on June 3, 2025, in Paris. The acquisition brings clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. McDermott advised ILife Consulting on the acquisition.
• Comac MedicalcoreOthersILife Consulting is part of Comac Medical Group, bringing clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. Described as a sister company.
• Niche CRO PartnerssupportingChannel Partner/ Reseller/ DistributorEstablished partnerships with niche CROs in selected countries and North America to meet the market strategy and operational needs of clients.
• Vendor PartnerssupportingTechnology or IntegrationPartnerships with data management, statistics, vigilance service providers, eSolutions providers (eCRF, eDiary/eCOA, IRT, eTMF), clinical trial supplies and operational supplies vendors.
• Oncology Clinical Trial Sites NetworksupportingChannel Partner/ Reseller/ DistributorPartnership with a global, exemplary Oncology clinical trial sites network to support oncology trial execution.
• Paris Saclay Cancer ClustersupportingStrategic or Co-development PartnerActive member of PSCC Connect network, contributing to a collaborative ecosystem that brings together start-ups, scientific experts and leading institutions to accelerate development of next-generation cancer treatments across Europe.
• ATCG PartnerssupportingImplementation/ SI/ Consulting PartnerProduction, management and editorial services provider for the company website.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medpace Holdings: US-based, mid-sized full-service CRO focused on small-to-mid biotech sponsors, with strong therapeutic expertise in oncology and early-phase trials — closely matches ILife's biotech-focused, scientifically-led positioning.
• Comac Medical Group: Pan-European full-service CRO platform that acquired ILife in June 2025; offers directly overlapping clinical operations, regulatory, and early-phase services to biotech sponsors across Europe.
• Worldwide Clinical Trials: Mid-sized scientific CRO serving small and mid-sized biotech and pharma; known for therapeutic specialization in oncology and rare disease — a directly comparable specialty CRO peer.
• Ergomed (Asahi Kasei): Specialty CRO historically focused on oncology and rare disease for small-mid biotech sponsors; merged with Premier Research after acquisition by Asahi Kasei — directly comparable therapeutic and customer profile.
• PSI CRO: European-headquartered full-service CRO with strong biotech sponsor focus and therapeutic specialization; directly comparable size, geography, and biotech customer base.
• Clinipace Worldwide: Mid-sized CRO historically serving emerging biotech and mid-sized pharma; comparable in scale and therapeutic focus, particularly in oncology.
• Premier Research: Specialty CRO with deep focus on oncology, rare disease, and innovative modalities for small-mid biotech; very comparable customer profile and scientific service orientation.
• CTI Clinical Trial & Consulting Services: Mid-sized CRO with strong biotech and oncology focus and academic trial experience; overlapping target customers and therapeutic emphasis.

Broad incumbents

• IQVIA: Largest global CRO and life science services firm; competes in clinical operations for biotech sponsors but operates at much greater scale and breadth than ILife.
• Parexel International: Large global full-service CRO competing for biotech Phase I–IV work; includes specialist biotech-oriented units (e.g., after the PAREXEL split), representing a broad incumbent alternative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ilifeconsulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ILife Consulting